Philips, American College of Cardiology and MedAxiom Collaborate to Shape the Future of Cardiovascular Care Delivery

Companies in the Global Vaccine Delivery Devices Market Expedite Product Innovations to Stay at Forefront in the Market in the COVID-19 Pandemic

Fact.MR has recently compiled a report, which reveals that the vaccine delivery devices market globally is projected to reflect an impressive CAGR over the forecast period, 2017 – 2022.

Sirtex Medical and BlackSwan Vascular Report 1st Patient Enrolled in Pivotal LAVA Study

The LAVA Study, which stands for Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature, is a prospective, multicenter single-arm study of 113 subjects at 20 investigational sites in the U.S.

March 11, 2021

Royal Philips, the American College of Cardiology and MedAxiom, an ACC company with the same mission, today announced a collaboration to deliver timely and actionable information along with guidance to align physicians, operations, and finance stakeholders.

The goal of the collaboration is to drive significant performance improvements in integrated cardiovascular care in terms of the patient and care provider experience, clinical outcomes, and productivity.

Cardiovascular disease is the leading cause of death globally, taking an estimated 17.9 million lives per year [1]. In the United States alone, total costs of cardiovascular disease are expected to reach $1.1 trillion in 2035, of which direct medical costs are projected to reach $749 billion [2]. Providers who care for this population face numerous challenges, including a lack of a model for optimizing performance and a void of data or data that are not actionable. To address these challenges, Philips will leverage its cardiovascular R&D and clinical expertise, ACC will provide knowledge that leverages the skill and expertise of more than 54,000 members, and MedAxiom will contribute premier organizational performance solutions.

“The ACC is mission driven to transform cardiovascular care and improve heart health, and we embrace innovative ways of supporting clinicians and the entire cardiovascular care team,” said Cathleen C. Gates, chief executive officer, ACC. “By combining Philips’ depth of knowledge in cardiac care delivery with ACC’s robust guideline and clinical document offerings, we’re ensuring clinicians have access to guideline-driven best practices in an impactful way.”

“MedAxiom is excited to collaborate with the ACC and Philips to bring together clinical leadership and strategic alignment aimed at improving clinical, financial and operational outcomes for cardiovascular service providers,” said Gerald Blackwell, MD, MBA, FACC, president and chief executive officer, MedAxiom. “Given the rapidly changing healthcare environment, we must leverage innovative models designed not only to optimize the way care is delivered and achieve the Quadruple Aim, but to truly transform cardiovascular care.”

“As the delivery of cardiac care faces many challenges, we are implementing integrated solutions and new approaches to help make healthcare delivery more efficient and effective,” said Bert van Meurs, Executive Vice President and Chief Business Leader of Image Guided Therapy at Royal Philips. “By collaborating with ACC and MedAxiom we will advance personalized, efficient and clinically-smart cardiac care that drives optimal outcomes throughout the patient journey.”

Philips Integrated Cardiovascular Solutions – combining systems, devices, informatics and services – provide the clinical confidence needed to deliver the right care at the right time. This powerful ecosystem cuts across the full spectrum of cardiac services with the goal of optimizing length of stay while reducing readmissions, providing data integration for improved insights and procedural performance. Learnings from this work alongside those provided by the ACC and MedAxiom will empower cardiovascular service providers with data, education and services to enable providers to optimize efficiency and reduce total cost of care, while continuing to provide the highest quality levels.

Breaking down silos; driving care transformation

Built on a foundation of aligned purpose, strategic fit and complementary visions, collaboration between the organizations to bring forward longitudinal solutions and next-generation business models in cardiovascular care has already begun. Philips, the ACC and MedAxiom have identified inadequacies exposed by COVID-19 and have used this knowledge to help cardiovascular groups begin to reframe their cardiovascular care delivery. Supporting this innovation is the TRIAD Model, which since the fall of 2020 has brought together physician, healthcare administrator and industry leaders to innovate the delivery of cardiovascular care through shared accountability and shared risk. A podcast series with insights from participants in the initiative is available here.

spot_img

DON'T MISS

Related Articles